The headlines of a newspaper on this page were generated automatically by a computer program.
このページのコンテンツは コンピュータプログラム で自動的に作成されています。
JAPANESE MAIN RSS feed RSS feed
updatenews @ hr.sub.jp
本システムについて





WORLD

BUSINESS

SPORTS

TECHNOLOGY

社会

政治

国際

経済

テクノロジー

スポーツ

エンターテイメント

科学
twitter hashtag summary
twitter trend
speech separation
large number Retweet
talking summarization
alarming description

real time translation turndown translation
      Drug mancemently incre adverse MS brain damage


      lead researcher professor alastair compston said: a e uzumab is the most promising experimentional drug for the treatment of multiple sclerosis, and we are hopeful that the phase three trials will confirm that it can both stabilise and allow some recovery of what had previously been assumed to be irreversible disabilities .
      in countrastudy, people giventional interferon-beta showed signs of progressively worsening disability .
      a e uzumab also reduced the trisk of suggestatined accumulation of disability by 71% compared to beta-interferon .
      we are witnessing a drug which, if given learly enough, might effectively stop the advancement of the disease and also restore lost founction by promoting repair of the damaged brain tissue .
      this damage prevents, the numberves from 'firing' properly, and then leads to theither destruction, resulting in physical and intellectual disabilities .
      Generated 2008-10-27_13:55





blogsphere accumulation         blog